Novartis (Rights for Cibacen and Cibadrex) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Novartis (Rights for Cibacen and Cibadrex) General Information

Description

A portfolio of rights of two pharmaceutical drugs. The drugs mainly used for the treatment of hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Acquirer
Corporate Office
  • P.O. Box CH - 4002
  • Basel
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Rights for Cibacen and Cibadrex) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request a free trial

Novartis (Rights for Cibacen and Cibadrex) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request a free trial

Novartis (Rights for Cibacen and Cibadrex) FAQs

  • Where is Novartis (Rights for Cibacen and Cibadrex) headquartered?

    Novartis (Rights for Cibacen and Cibadrex) is headquartered in Basel, Switzerland.

  • What industry is Novartis (Rights for Cibacen and Cibadrex) in?

    Novartis (Rights for Cibacen and Cibadrex)’s primary industry is Buildings and Property.

  • Is Novartis (Rights for Cibacen and Cibadrex) a private or public company?

    Novartis (Rights for Cibacen and Cibadrex) is a Private company.

  • What is the current valuation of Novartis (Rights for Cibacen and Cibadrex)?

    The current valuation of Novartis (Rights for Cibacen and Cibadrex) is 00000.

  • What is Novartis (Rights for Cibacen and Cibadrex)’s current revenue?

    The current revenue for Novartis (Rights for Cibacen and Cibadrex) is 000000.

  • Who are Novartis (Rights for Cibacen and Cibadrex)’s investors?

    Novartis has invested in Novartis (Rights for Cibacen and Cibadrex).

  • When was Novartis (Rights for Cibacen and Cibadrex) acquired?

    Novartis (Rights for Cibacen and Cibadrex) was acquired on 20-Jan-2005.

  • Who acquired Novartis (Rights for Cibacen and Cibadrex)?

    Novartis (Rights for Cibacen and Cibadrex) was acquired by Meda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »